Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
NCT02015494
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
316
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
VAX2012Q
Sponsor
VaxInnate Corporation